G proteins are molecules activated by their binding with G protein-coupled receptors (GPCRs).
<h3>What are G proteins?</h3>
G proteins are proteins that act during cellular signaling to transmit information via molecular cascades.
G proteins act by their binding with suitable ligand, where G protein-coupled receptors bind to the G protein and it triggers a molecular cascade.
In conclusion, G proteins are molecules activated by their binding with G protein-coupled receptors (GPCRs).
Learn more about G proteins here:
brainly.com/question/1305997
#SPJ12
Answer:
<em>The ability of a specific tissue or organ to respond to the presence of a hormone is dependent on the presence of the appropriate receptors on the cells of the target tissue or organ- C.</em>
Answer:
The answer to the question: These cells provide for the sense of smell:___, would be, A: Olfactory hair cells.
Explanation:
The sense of smell might be one of the most primitive, but also one of the most amazing senses of the human system. This sense initiates with the introduction of smells, in the form of chemical molecules dissolved in air, that once they come into contact with the mucus in the nostrils dissolve and reach a group of cells, on the olfactory epithelium known as the olfactory receptor neurons. These cells capture the chemicals and send neural signals towards the olfactory bulbs, where sensory neurons relay the messages towards the brain centers. In the brain, several steps take place in order to gain sense, comprehension and assimilation of the smell that has been captured.
According to a study, venetoclax plus hypomethylating agent is effective in newly diagnosed acute myeloid leukemia, and safe in an outpatient setting. So the statement is true.
<h3>What is venetoclax?</h3>
Venetoclax is either used alone or in combination with another drug called obinutuzumab or rituximab. This is used for the treatment of certain types of chronic lymphocytic leukemia. It is a type of cancer that develops in white blood cells. It is also used for certain types of small lymphocytic lymphoma, which is a type of cancer that develops in the lymph nodes.
It can also be used in combination with either azacitidine, decitabine, or cytarabine. This is done as the initial treatment for acute myeloid leukemia, which is a type of cancer that begins in the white blood cells in people who are 75 years or older. It can also develop in adults having medical conditions that prevent them from being treated with any other treatment than chemotherapy medications.
The class of medications from which Venetoclax belongs is called B-cell lymphoma-2 inhibitors. These medicines work by blocking the action of a particular protein in the body that promotes cancer cells' survival. This helps in killing cancer cells.
Therefore, the statement is true.
Read more about leukemia, here
brainly.com/question/5868856
#SPJ4
Explanation:
hi how are you I'm fine and you have a nice day
